Evidence map›Paper›PMID 19091445›Full record

ArticleNeurobiology of aging2010

Coronary heart disease is associated with non-amnestic mild cognitive impairment.

Rosebud O Roberts, David S Knopman, Yonas E Geda, Ruth H Cha, Véronique L Roger, Ronald C Petersen

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neurobiology of aging, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico.Journal of the International Neuropsychological Society : JINS · 2022
    Article
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rosebud O RobertsMayo Clinic, Department of Health Sciences Research, Division of Epidemiology, 200 First Street SW, Rochester, MN 55905, United States. roberts.rosebud@mayo.edu
David S Knopman
Yonas E Geda
Ruth H Cha
Véronique L Roger
Ronald C Petersen
Mayo Clinic · USMayo Clinic in Florida · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 1999 to 2018
$36.9M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
ROCHESTER EPIDEMIOLOGY PROJECTR01AR030582 · NIAMS · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A · 1986 to 2009
$5.1M
Psychiatric Characterization/Mild Cognitive ImpairmentK01MH068351 · NIMH · MAYO CLINIC ROCHESTER · PI GEDA, YONAS E · 2004 to 2008
$890k
Vascular /Inflammatory Predictors of MCI Risk /ProgressiK01AG028573 · NIA · MAYO CLINIC ROCHESTER · PI ROBERTS, ROSEBUD O · 2006 to 2008
$351k
NIAMS NIH HHS R01 AR030582NIA NIH HHS K01 AG 028573NIA NIH HHS K01 AG028573NIA NIH HHS P50 AG016574NIA NIH HHS P50 AG 16574NIA NIH HHS R01 AG034676NIA NIH HHS U01 AG006786NIA NIH HHS U01AG06786NIMH NIH HHS K01 MH068351NIMH NIH HHS K01 MH 68351
6 · The paper itself

Abstract

The progression of amnestic mild cognitive impairment (a-MCI) to Alzheimer's disease and hypothesized progression of non-amnestic mild cognitive impairment (na-MCI) to non-degenerative or vascular dementias suggest etiologic differences. We examined the association between coronary heart disease (CHD) and mild cognitive impairment (MCI) subtypes in a population-based cohort. Participants (n=1969; aged 70-89 years) were evaluated using the Clinical Dementia Rating Scale, a neurological examination, and neuropsychological testing for diagnoses of normal cognition, MCI, or dementia. CHD was defined as a history of myocardial infarction, angina, angiographic coronary stenosis, or coronary revascularization and ascertained by participant interview and from medical records. CHD was significantly associated with na-MCI (OR=1.93; 95% CI=1.22-3.06) but not with a-MCI (OR=0.94; 95% CI=0.69-1.28). In contrast, ApoE ɛ4 allele was significantly associated with a-MCI (OR=1.75; 95% CI=1.28-2.41), but not with na-MCI (OR=1.17; 95% CI=0.69-2.00). The association of CHD with prevalent na-MCI but not with a-MCI suggests that CHD and na-MCI may have similar underlying etiologies.

Indexed as

AgedAged, 80 and overAmnesiaApolipoprotein E4Case-Control StudiesCognition DisordersCohort StudiesComorbidityCoronary DiseaseCross-Sectional StudiesDementiaFemaleHumansLongitudinal StudiesMaleMinnesotaApolipoprotein E4

Identifiers

PMID19091445
PMCPMC2888961
OpenAlexW2038857539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.